inclusion criteria: * age: 60 years or older * males and females * able and willing (in the investigator's opinion) to comply with all study requirements. * participants, who already received three covid-19 vaccines, of which the third was a mrna vaccine (bnt162b2 or mrna-1273) and at least 16 weeks ago * only applicable for women: last menstrual bleeding more than one year ago

inclusion criteria: * age: 60 years or older * males and females * able and willing (in the investigator's opinion) to comply with all study requirements. * participants, who already received three covid-19 vaccines, of which the third was a mrna vaccine (bnt162b2 or mrna-1273) and at least 16 weeks ago * only applicable for women: last menstrual bleeding more than one year ago

inclusion criteria: age: 60 years or older males and females able and willing (in the investigator's opinion) to comply with all study requirements. participants, who already received three covid-19 vaccines, of which the third was a mrna vaccine (bnt162b2 or mrna-1273) and at least 16 weeks ago only applicable for women: last menstrual bleeding more than one year ago

inclusion criteria: age: 60 years or older males and females able and willing (in the investigator's opinion) to comply with all study requirements. participants, who already received three covid-19 vaccines, of which the third was a mrna vaccine (bnt162b2 or mrna-1273) and at least 16 weeks ago only applicable for women: last menstrual bleeding more than one year ago